AI assistant
Sending…
STIFEL FINANCIAL CORP — Director's Dealing 2013
Aug 15, 2013
30525_dirs_2013-08-15_b93f674f-6119-462d-91a5-752c81ecfad7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STIFEL FINANCIAL CORP (SF)
CIK: 0000720672
Period of Report: 2013-08-13
Reporting Person: WEISEL THOMAS W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-13 | Common Stock | S | 150000 | $40.1397 | Disposed | 263038 | Direct |
| 2013-08-14 | Common Stock | G | 40991 | — | Disposed | 222047 | Direct |
| 2013-08-15 | Common Stock | G | 78342 | — | Disposed | 143705 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 156686 | Indirect |
| Common Stock | 18231 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Units | $0 | Common Stock (60837) | 60837 | Direct |
Footnotes
F1: These shares were sold pursuant to a 10(b)5-1 Plan.
F2: This transaction was executed in multiple trades at prices ranging from $39.78 to $40.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Units vest in 20% increments over a five year period.
F4: No expiration date for these Units.
More from STIFEL FINANCIAL CORP
Regulatory Filings
2026
May 28
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 17